It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
There are different characteristics of BC in developing countries and developed countries. We intended to study the factors which influence the survival and prognosis of BC between southern China and the United States. (a) To study the two groups BC patients in southern China from 2001 to 2016 and SEER database from 1975 to 2016. (b) To register, collect and analyze the clinicopathological features and treatment information. Our study found that there are significant differences in tumor size, positive lymph node status and KI-67 between southern China and SEER cohort (P < 0.000). The positive lymph node status may be one of the causes of difference of morbidity and mortality of BC patients in China. Furthermore, the differences in treatment methods may also account for the differences between China and seer databases.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Yunnan Cancer Hospital, Department of Hepatobiliary and Pancreatic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, People’s Republic of China (GRID:grid.452826.f); Yunnan Cancer Hospital, Department of Breast Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, People’s Republic of China (GRID:grid.452826.f)
2 Affiliated Tumor Hospital of Guangxi Medical University, Department of Breast Surgery, Nanning, People’s Republic of China (GRID:grid.413431.0)
3 The Third Affiliated Hospital of Kunming Medical University, Department of Ultrasound, Caner Hospital of Yunnan Province, Kunming, People’s Republic of China (GRID:grid.452826.f)
4 The First People’s Hospital of Foshan, Department of Breast Surgery, Foshan, People’s Republic of China (GRID:grid.452881.2) (ISNI:0000 0004 0604 5998)
5 Yunnan Cancer Hospital, Department of Hepatobiliary and Pancreatic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, People’s Republic of China (GRID:grid.452826.f)
6 Yunnan Cancer Hospital, Department of Breast Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, People’s Republic of China (GRID:grid.452826.f)